Trial intelligence / Profile preview

CORAL-2: High-Dose Peginterferon Induction in HCV/HIV Coinfection

NCT00356486Phase 4Completed

Sponsor
Hospital Universitari Germans Trias i Pujol
Start
Oct 2005
Primary completion
Mar 2009
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 4 trial of peginterferon alfa-2a, ribavirin in chronic hepatitis C (CHC), sponsored by Hospital Universitari Germans Trias i Pujol. Started Oct 2005; status: completed.

02

Drugs

peginterferon alfa-2aribavirin
03

Conditions

chronic hepatitis C (CHC)

Beyond the preview

Go deeper on NCT00356486.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00356486.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call